Marimastat (BioDeep_00000033263)
human metabolite blood metabolite Chemicals and Drugs
代谢物信息卡片
(2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide
化学式: C15H29N3O5 (331.2107104)
中文名称: 马立马司他
谱图信息:
最多检出来源 Homo sapiens(blood) 95.92%
分子结构信息
SMILES: CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C
InChI: InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1
描述信息
Marimastat is only found in individuals that have used or taken this drug. It is used in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.Marimastat is a broad spectrum matrix metalloprotease inhibitor. It mimics the peptide structure of natural MMP substrates and binds to matrix metalloproteases, thereby preventing the degradation of the basement membrane by these proteases. This antiprotease action prevents the migration of endothelial cells needed to form new blood vessels. Inhibition of MMPs also prevents the entry and exit of tumor cells into existing blood cells, thereby preventing metastasis.
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
D004791 - Enzyme Inhibitors
同义名列表
数据库引用编号
8 个数据库交叉引用编号
- ChEBI: CHEBI:50662
- PubChem: 119031
- HMDB: HMDB0014924
- DrugBank: DB00786
- ChEMBL: CHEMBL279785
- Wikipedia: Marimastat
- chemspider: 106358
- CAS: 154039-60-8
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Ariel Buchler, Uzair S Ismailani, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Christina Bi, Catherine Jany, Jeffrey W Keillor, Benjamin H Rotstein. Quinazoline-2-Carboxamides as Selective PET Radiotracers for Matrix Metalloproteinase-13 Imaging in Atherosclerosis.
Journal of medicinal chemistry.
2023 05; 66(10):6682-6696. doi:
10.1021/acs.jmedchem.2c02107. [PMID: 37158732] - Tamara L Young, Ekaterina Mostovenko, Jesse L Denson, Jessica G Begay, Selita N Lucas, Guy Herbert, Katherine Zychowski, Russell Hunter, Raul Salazar, Ting Wang, Kelly Fraser, Aaron Erdely, Andrew K Ottens, Matthew J Campen. Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation.
Particle and fibre toxicology.
2021 09; 18(1):34. doi:
10.1186/s12989-021-00427-w. [PMID: 34496918] - Abhinandan Chowdhury, Christina N Zdenek, James S Dobson, Lachlan A Bourke, Raul Soria, Bryan G Fry. Clinical implications of differential procoagulant toxicity of the palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors.
Toxicology letters.
2021 Apr; 340(?):77-88. doi:
10.1016/j.toxlet.2020.12.019. [PMID: 33412251] - Kyung Chan Park, Mahendiran Dharmasivam, Des R Richardson. The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.
International journal of molecular sciences.
2020 Sep; 21(18):. doi:
10.3390/ijms21186805. [PMID: 32948029] - Harry J Layfield, Harry F Williams, Divyashree Ravishankar, Amita Mehmi, Medha Sonavane, Anika Salim, Rajendran Vaiyapuri, Karthik Lakshminarayanan, Thomas M Vallance, Andrew B Bicknell, Steven A Trim, Ketan Patel, Sakthivel Vaiyapuri. Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox.
Toxins.
2020 05; 12(5):. doi:
10.3390/toxins12050309. [PMID: 32397419] - Abeer H A Mohamed-Ahmed, Alastair Lockwood, Hala Fadda, Shivam Madaan, Peng T Khaw, Steve Brocchini, Kersti Karu. LC-MS analysis to determine the biodistribution of a polymer coated ilomastat ocular implant.
Journal of pharmaceutical and biomedical analysis.
2018 Aug; 157(?):100-106. doi:
10.1016/j.jpba.2018.05.017. [PMID: 29777984] - Peter G Ruminski, Mark Massa, Joseph Strohbach, Cathleen E Hanau, Michelle Schmidt, Jeffrey A Scholten, Theresa R Fletcher, Bruce C Hamper, Jeffery N Carroll, Huey S Shieh, Nicole Caspers, Brandon Collins, Margaret Grapperhaus, Katherine E Palmquist, Joe Collins, John E Baldus, Jeffrey Hitchcock, H Peter Kleine, Michael D Rogers, Joseph McDonald, Grace E Munie, Dean M Messing, Silvia Portolan, Laurence O Whiteley, Teresa Sunyer, Mark E Schnute. Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.
Journal of medicinal chemistry.
2016 Jan; 59(1):313-27. doi:
10.1021/acs.jmedchem.5b01434. [PMID: 26653735] - Claire Underwood, Simon N Collins, Andrew W van Eps, Paul C Mills, Rachel E Allavena, Simon R Bailey, Carlos E Medina Torres, Alon Meizler, Christopher C Pollitt. Intraosseous infusion of the distal phalanx compared to systemic intravenous infusion for marimastat delivery to equine lamellar tissue.
Veterinary journal (London, England : 1997).
2015 Sep; 205(3):357-63. doi:
10.1016/j.tvjl.2015.05.010. [PMID: 26073286] - C Underwood, S N Collins, P C Mills, A W Van Eps, R E Allavena, C E Medina Torres, C C Pollitt. Regional intravenous limb perfusion compared to systemic intravenous administration for marimastat delivery to equine lamellar tissue.
Journal of veterinary pharmacology and therapeutics.
2015 Aug; 38(4):392-9. doi:
10.1111/jvp.12198. [PMID: 25641095] - Aura D Urribarri, Patricia Munoz-Garrido, María J Perugorria, Oihane Erice, Maite Merino-Azpitarte, Ander Arbelaiz, Elisa Lozano, Elizabeth Hijona, Raúl Jiménez-Agüero, Maite G Fernandez-Barrena, Juan P Jimeno, Marco Marzioni, Jose J G Marin, Tatyana V Masyuk, Nicholas F LaRusso, Jesús Prieto, Luis Bujanda, Jesús M Banales. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
Gut.
2014 Oct; 63(10):1658-67. doi:
10.1136/gutjnl-2013-305281. [PMID: 24436140] - Zhen Guo, Xunbo Jin, Haiyan Jia. Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma.
Journal of experimental & clinical cancer research : CR.
2013 May; 32(?):26. doi:
10.1186/1756-9966-32-26. [PMID: 23659326] - Janina Lenger, Farnusch Kaschani, Thomas Lenz, Christian Dalhoff, Joji Grace Villamor, Hubert Köster, Norbert Sewald, Renier A L van der Hoorn. Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe.
Bioorganic & medicinal chemistry.
2012 Jan; 20(2):592-6. doi:
10.1016/j.bmc.2011.06.068. [PMID: 21775155] - Renier A L van der Hoorn, Tom Colby, Sabrina Nickel, Kerstin H Richau, Jürgen Schmidt, Markus Kaiser. Mining the Active Proteome of Arabidopsis thaliana.
Frontiers in plant science.
2011; 2(?):89. doi:
10.3389/fpls.2011.00089. [PMID: 22639616] - Vincent E de Meijer, Deanna Y Sverdlov, Yury Popov, Hau D Le, Jonathan A Meisel, Vânia Nosé, Detlef Schuppan, Mark Puder. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
PloS one.
2010 Jun; 5(6):e11256. doi:
10.1371/journal.pone.0011256. [PMID: 20593020] - Katherine B Novak, Hau D Le, Emily R Christison-Lagay, Vania Nose, Robert J Doiron, Marsha A Moses, Mark Puder. Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury.
Pediatric research.
2010 Mar; 67(3):257-62. doi:
10.1203/pdr.0b013e3181ca0aa2. [PMID: 19915515] - Marion Flipo, Julie Charton, Akila Hocine, Sandrine Dassonneville, Benoit Deprez, Rebecca Deprez-Poulain. Hydroxamates: relationships between structure and plasma stability.
Journal of medicinal chemistry.
2009 Nov; 52(21):6790-802. doi:
10.1021/jm900648x. [PMID: 19821586] - Fumio Tsuji, Miwa Yoshimi, Osamu Katsuta, Miwa Takai, Katsuhiko Ishihara, Hiroyuki Aono. Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice.
BMC musculoskeletal disorders.
2009 Feb; 10(?):23. doi:
10.1186/1471-2474-10-23. [PMID: 19228423] - Ian P J Alwayn, Jennifer E Verbesey, Sendia Kim, Roopali Roy, Danielle A Arsenault, Arin K Greene, Katherine Novak, Andrea Laforme, Sang Lee, Marsha A Moses, Mark Puder. A critical role for matrix metalloproteinases in liver regeneration.
The Journal of surgical research.
2008 Apr; 145(2):192-8. doi:
10.1016/j.jss.2007.04.002. [PMID: 18222481] - Ian P J Alwayn, Charlotte Andersson, Sang Lee, Danielle A Arsenault, Bruce R Bistrian, Kathleen M Gura, Vania Nose, Blanca Zauscher, Marsha Moses, Mark Puder. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
American journal of physiology. Gastrointestinal and liver physiology.
2006 Dec; 291(6):G1011-9. doi:
10.1152/ajpgi.00047.2006. [PMID: 16844679] - Stanley Zucker, Molin Wang, Joseph A Sparano, William J Gradishar, James N Ingle, Nancy E Davidson. Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Clinical breast cancer.
2006 Feb; 6(6):525-9. doi:
10.3816/cbc.2006.n.006. [PMID: 16595036] - Eli Rosenbaum, Marianna Zahurak, Victoria Sinibaldi, Michael A Carducci, Roberto Pili, Menachem Laufer, Theodore L DeWeese, Mario A Eisenberger. Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2005 Jun; 11(12):4437-43. doi:
10.1158/1078-0432.ccr-04-2252. [PMID: 15958628] - John R Goffin, Ian C Anderson, Jeffrey G Supko, Joseph Paul Eder, Geoffrey I Shapiro, Thomas J Lynch, Margaret Shipp, Bruce E Johnson, Arthur T Skarin. Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2005 May; 11(9):3417-24. doi:
10.1158/1078-0432.ccr-04-2144. [PMID: 15867243] - G J Caine, A L Harris, K Christodoulos, G Y H Lip, A D Blann. Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Cancer letters.
2005 Mar; 219(2):163-7. doi:
10.1016/j.canlet.2004.09.036. [PMID: 15723715] - Roopali Roy, Ulla M Wewer, David Zurakowski, Susan E Pories, Marsha A Moses. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
The Journal of biological chemistry.
2004 Dec; 279(49):51323-30. doi:
10.1074/jbc.m409565200. [PMID: 15381692] - Joseph A Sparano, Patricia Bernardo, Patricia Stephenson, William J Gradishar, James N Ingle, Stanley Zucker, Nancy E Davidson. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2004 Dec; 22(23):4683-90. doi:
10.1200/jco.2004.08.054. [PMID: 15570070] - G Deplanque, S Madhusudan, P H Jones, S Wellmann, K Christodoulos, D C Talbot, T S Ganesan, A Blann, A L Harris. Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.
British journal of cancer.
2004 Nov; 91(9):1645-50. doi:
10.1038/sj.bjc.6602126. [PMID: 15354209] - P H Jones, K Christodoulos, N Dobbs, P Thavasu, F Balkwill, A D Blann, G J Caine, S Kumar, A J Kakkar, N Gompertz, D C Talbot, T S Ganesan, A L Harris. Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
British journal of cancer.
2004 Jul; 91(1):30-6. doi:
10.1038/sj.bjc.6601897. [PMID: 15162145] - G La Rocca, I Pucci-Minafra, A Marrazzo, P Taormina, S Minafra. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.
British journal of cancer.
2004 Apr; 90(7):1414-21. doi:
10.1038/sj.bjc.6601725. [PMID: 15054465] - Deborah L Toppmeyer, Murugesan Gounder, Judie Much, Rita Musanti, Viral Vyas, Melissa Medina, Tammy Orlando, Michael Pennick, Yong Lin, Weichung Shih, Susan Goodin, Eric Rubin. A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy.
Medical science monitor : international medical journal of experimental and clinical research.
2003 Aug; 9(8):PI99-104. doi:
NULL. [PMID: 12942041] - Michel Neidhart, Christian A Seemayer, Klaus M Hummel, Beat A Michel, Renate E Gay, Steffen Gay. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo.
Arthritis and rheumatism.
2003 Jul; 48(7):1873-80. doi:
10.1002/art.11166. [PMID: 12847681] - B Hanke, A Wein, P Martus, C Riedel, M Voelker, E G Hahn, D Schuppan. Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy.
British journal of cancer.
2003 Apr; 88(8):1248-50. doi:
10.1038/sj.bjc.6600832. [PMID: 12698191] - K D Miller, W Gradishar, L Schuchter, J A Sparano, M Cobleigh, N Robert, H Rasmussen, G W Sledge. A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology.
2002 Aug; 13(8):1220-4. doi:
10.1093/annonc/mdf199. [PMID: 12181245] - Karen E Porter, Jagjeeth Naik, Neil A Turner, Timothy Dickinson, Matthew M Thompson, Nicholas J M London. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
Journal of vascular surgery.
2002 Jul; 36(1):150-7. doi:
10.1067/mva.2002.122029. [PMID: 12096273] - Georg Kottirsch, Guido Koch, Roland Feifel, Ulf Neumann. Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.
Journal of medicinal chemistry.
2002 May; 45(11):2289-93. doi:
10.1021/jm0110993. [PMID: 12014967] - L D Ofner, N M Hooper. Ectodomain shedding of cystinyl aminopeptidase from human placental membranes.
Placenta.
2002 Jan; 23(1):65-70. doi:
10.1053/plac.2001.0751. [PMID: 11869093] - W P Steward, A L Thomas. Marimastat: the clinical development of a matrix metalloproteinase inhibitor.
Expert opinion on investigational drugs.
2000 Dec; 9(12):2913-22. doi:
10.1517/13543784.9.12.2913. [PMID: 11093361] - M Tahara, Y Sasaki. [Dose escalation strategies of molecular target drugs].
Gan to kagaku ryoho. Cancer & chemotherapy.
2000 Oct; 27(11):1759-63. doi:
NULL. [PMID: 11057331] - M Peterson, K E Porter, I M Loftus, M M Thompson, N J London. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
2000 May; 19(5):461-7. doi:
10.1053/ejvs.1999.1041. [PMID: 10828225] - N M Hooper, A J Trew, E T Parkin, A J Turner. The role of proteolysis in Alzheimer's disease.
Advances in experimental medicine and biology.
2000; 477(?):379-90. doi:
10.1007/0-306-46826-3_39. [PMID: 10849764] - H North, J King, D L Morris. Effect of marimastat on serum tumour markers in patients with colorectal cancer.
International journal of surgical investigation.
2000; 2(3):213-7. doi:
NULL. [PMID: 12678521] - S A Watson, T M Morris, H M Collins, L J Bawden, K Hawkins, E A Bone. Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA.
British journal of cancer.
1999 Sep; 81(1):19-23. doi:
10.1038/sj.bjc.6690645. [PMID: 10487607] - J N Primrose, H Bleiberg, F Daniel, S Van Belle, J L Mansi, M Seymour, P W Johnson, J P Neoptolemos, M Baillet, K Barker, A Berrington, P D Brown, A W Millar, K P Lynch. Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.
British journal of cancer.
1999 Feb; 79(3-4):509-14. doi:
10.1038/sj.bjc.6690079. [PMID: 10027321] - W P Steward. Marimastat (BB2516): current status of development.
Cancer chemotherapy and pharmacology.
1999; 43 Suppl(?):S56-60. doi:
10.1007/s002800051099. [PMID: 10357560] - K E Porter, I M Loftus, M Peterson, P R Bell, N J London, M M Thompson. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis.
The British journal of surgery.
1998 Oct; 85(10):1373-7. doi:
10.1046/j.1365-2168.1998.00888.x. [PMID: 9782017] - S Wojtowicz-Praga, J Torri, M Johnson, V Steen, J Marshall, E Ness, R Dickson, M Sale, H S Rasmussen, T A Chiodo, M J Hawkins. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1998 Jun; 16(6):2150-6. doi:
10.1200/jco.1998.16.6.2150. [PMID: 9626215] - J Nemunaitis, C Poole, J Primrose, A Rosemurgy, J Malfetano, P Brown, A Berrington, A Cornish, K Lynch, H Rasmussen, D Kerr, D Cox, A Millar. Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1998 May; 4(5):1101-9. doi:
NULL. [PMID: 9607566] - A W Millar, P D Brown, J Moore, W A Galloway, A G Cornish, T J Lenehan, K P Lynch. Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers.
British journal of clinical pharmacology.
1998 Jan; 45(1):21-6. doi:
10.1046/j.1365-2125.1998.00639.x. [PMID: 9489589] - I N Golovistikov. [Ability of antilymphocyte sera to counteract the allogeneic inhibition of hematopoietic stem cells].
Doklady Akademii nauk SSSR.
1975 Aug; 223(5):1245-7. doi:
NULL. [PMID: 222]